false --12-31 0000820313 0000820313 2025-05-15 2025-05-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 15, 2025

 

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   1-10879   22-2785165

(State or other jurisdiction of incorporation)

  (Commission File Number)   (IRS Employer Identification No.)

 

358 Hall Avenue, Wallingford, Connecticut   06492
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (203) 265-8900

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A Common Stock, $0.001 par value APH New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On May 15, 2025, the stockholders of Amphenol Corporation (the “Company”) approved an amendment to the Company’s Restated Certificate of Incorporation to amend Article FOURTH thereof to increase the number of shares of Class A Common Stock, par value $.001 per share (“Common Stock”), that the Company is authorized to issue by 3 billion from 2 billion to 5 billion (the “Charter Amendment”).

 

The foregoing description of the Charter Amendment is qualified in its entirety by reference to the full text of the Charter Amendment, a copy of which is attached as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference. The Charter Amendment became effective upon filing with the Secretary of State of the State of Delaware on May 15, 2025.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders of the Company was held on May 15, 2025.  As of March 17, 2025, the record date for the meeting, 1,211,783,313 shares of Common Stock were outstanding.  A quorum of 1,103,209,527 shares were present or represented at the meeting.

 

The stockholders (i) elected each of the Company’s nominees for director, (ii) ratified the selection of Deloitte & Touche LLP as independent public accountants of the Company, (iii) approved the advisory vote to approve compensation of named executive officers, (iv) approved the Charter Amendment, and (v) did not approve a stockholder proposal regarding support for special shareholder meeting improvement.  The voting results for each item, all of which are described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 4, 2025, are as follows:

 

1. ELECTION OF EIGHT DIRECTORS

 

FOR the nominees:

 

NOMINEE FOR AGAINST ABSTAIN NON-VOTES
Nancy A. Altobello 1,045,736,833 10,969,311 1,832,153 44,671,230
David P. Falck 1,005,432,133 51,252,353 1,853,811 44,671,230
Rita S. Lane 1,052,780,519 3,430,230 2,327,548 44,671,230
Robert A. Livingston 1,023,506,546 33,180,026 1,851,725 44,671,230
Martin H. Loeffler 1,025,566,274 31,079,227 1,892,796 44,671,230
R. Adam Norwitt 1,053,453,223 4,290,165 794,909 44,671,230
Prahlad Singh 1,046,271,081 9,908,793 2,358,423 44,671,230
Anne Clarke Wolff 1,052,760,940 3,404,299 2,373,058 44,671,230

 

2. RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS

 

FOR 1,036,552,396   AGAINST 65,245,590
         
ABSTAIN 1,410,541   NON-VOTES 0

 

3.ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS

  

FOR 959,579,761   AGAINST 86,430,060
         
ABSTAIN 12,528,476   NON-VOTES 44,671,230

 

 

 

 

4.

APPROVAL OF AN AMENDMENT TO THE COMPANY’S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK

 

FOR 856,330,104   AGAINST 244,620,802
         
ABSTAIN 2,258,621   NON-VOTES 0

 

5. STOCKHOLDER PROPOSAL REGARDING SUPPORT FOR SPECIAL SHAREHOLDER MEETING IMPROVEMENT

 

FOR 121,557,433   AGAINST 934,612,439
         
ABSTAIN 2,368,425   NON-VOTES 44,671,230

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Document Description
3.1   Certificate of Amendment to the Restated Certificate of Incorporation of Amphenol Corporation
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMPHENOL CORPORATION
     
  By: /s/ Lance E. D’Amico
    Lance E. D’Amico
    Senior Vice President, Secretary and General Counsel
     
Date: May 16, 2025